Economy

D.E. Shaw takes $1 billion short bet on Bayer, regulatory filing shows

By Nell Mackenzie and Ludwig Burger

LONDON/FRANKFURT (Reuters) -Hedge fund D.E. Shaw took a 1.02 billion euro ($1.08 billion) short bet against Bayer (OTC:BAYRY) on Tuesday, a regulatory filing in Germany showed, following an earnings presentation that sent its shares to a 20-year low,

A short position reflects a view that the price of a financial asset will fall.

New York-based D.E. Shaw, one of the hedge fund industry’s biggest managers overseeing more than $60 billion in assets, declined to comment.

Bayer did not immediately comment.

Bayer warned on Tuesday that weak agricultural markets would be likely to cause further falls in next year’s earnings, after releasing a lower-then-expected quarterly adjusted profit.

The remarks presented by Chief Executive Bill Anderson sparked a sharp fall in the company’s shares and increased pressure on the CEO to deliver on his turnaround efforts.

Bayer shares fell to a new 20-year low on Wednesday closing the session 3.5% lower. On Tuesday, they fell as much as 15.8% from the previous day’s close.

($1 = 0.9444 euro)

This post appeared first on investing.com

You May Also Like

Editor's Pick

Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

Economy

A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

Latest News

A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

Investing

Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 balanceandcharge.com

Exit mobile version